APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgotinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Filgotinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025179 pages

Choose your research edition.

Industry ResearchFilgotinib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgotinib Tablets Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Filgotinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgotinib Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgotinib Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Filgotinib Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Filgotinib Tablets include Alfasigma, Gilead Sciences and Eisai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgotinib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgotinib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgotinib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgotinib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgotinib Tablets Segment by Company

Alfasigma

Gilead Sciences

Eisai

Filgotinib Tablets Segment by Type

100mg per Tablet

200mg per Tablet

Filgotinib Tablets Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Filgotinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgotinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgotinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgotinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgotinib Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Filgotinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Filgotinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Filgotinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Filgotinib Tablets Industry Trends Table 2. Filgotinib Tablets Industry Drivers Table 3. Filgotinib Tablets Industry Opportunities and Challenges Table 4. Filgotinib Tablets Industry Restraints Table 5. Global Filgotinib Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Filgotinib Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Filgotinib Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Filgotinib Tablets Sales Market Share by Manufacturers Table 9. Global Filgotinib Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Filgotinib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Filgotinib Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Filgotinib Tablets Manufacturers, Product Type & Application Table 13. Global Filgotinib Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgotinib Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg per Tablet Table 17. Major Manufacturers of 200mg per Tablet Table 18. Global Filgotinib Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Filgotinib Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Filgotinib Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Filgotinib Tablets Sales Market Share by Type (2021-2026) Table 22. Global Filgotinib Tablets Sales Market Share by Type (2027-2032) Table 23. Global Filgotinib Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Filgotinib Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Filgotinib Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Filgotinib Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Filgotinib Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacy Table 29. Major Manufacturers of Online Pharmacy Table 30. Major Manufacturers of Retail Pharmacy Table 31. Global Filgotinib Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Filgotinib Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Filgotinib Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Filgotinib Tablets Sales Market Share by Application (2021-2026) Table 35. Global Filgotinib Tablets Sales Market Share by Application (2027-2032) Table 36. Global Filgotinib Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Filgotinib Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Filgotinib Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Filgotinib Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Filgotinib Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Filgotinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Filgotinib Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Filgotinib Tablets Sales Market Share by Region (2021-2026) Table 44. Global Filgotinib Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Filgotinib Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Filgotinib Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Filgotinib Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Filgotinib Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Filgotinib Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Filgotinib Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Filgotinib Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Filgotinib Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Filgotinib Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Filgotinib Tablets Revenue Market Share by Region (2027-2032) Table 63. Alfasigma Company Information Table 64. Alfasigma Business Overview Table 65. Alfasigma Filgotinib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alfasigma Filgotinib Tablets Product Portfolio Table 67. Alfasigma Recent Development Table 68. Gilead Sciences Company Information Table 69. Gilead Sciences Business Overview Table 70. Gilead Sciences Filgotinib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Gilead Sciences Filgotinib Tablets Product Portfolio Table 72. Gilead Sciences Recent Development Table 73. Eisai Company Information Table 74. Eisai Business Overview Table 75. Eisai Filgotinib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eisai Filgotinib Tablets Product Portfolio Table 77. Eisai Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Filgotinib Tablets Distributors List Table 81. Filgotinib Tablets Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Filgotinib Tablets Product Image Figure 2. Global Filgotinib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgotinib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Filgotinib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Filgotinib Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Filgotinib Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg per Tablet Image Figure 9. 200mg per Tablet Image Figure 10. Global Filgotinib Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Filgotinib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Filgotinib Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Filgotinib Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Filgotinib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Filgotinib Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacy Image Figure 17. Online Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Global Filgotinib Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Filgotinib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Filgotinib Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Filgotinib Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Filgotinib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Filgotinib Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Filgotinib Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Filgotinib Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Filgotinib Tablets Sales Market Share by Country (2021-2032) Figure 39. China Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Filgotinib Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Filgotinib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Filgotinib Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Filgotinib Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Filgotinib Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Filgotinib Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Filgotinib Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Filgotinib Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Filgotinib Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Filgotinib Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Alfasigma
  • Gilead Sciences
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Filgotinib Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Filgotinib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Filgotinib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Filgotinib Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Filgotinib Tablets Market Dynamics
  1. 2.1 Filgotinib Tablets Industry Trends
  2. 2.2 Filgotinib Tablets Industry Drivers
  3. 2.3 Filgotinib Tablets Industry Opportunities and Challenges
  4. 2.4 Filgotinib Tablets Industry Restraints
3 Filgotinib Tablets Market by Manufacturers
  1. 3.1 Global Filgotinib Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Filgotinib Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Filgotinib Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Filgotinib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Filgotinib Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Filgotinib Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Filgotinib Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Filgotinib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Filgotinib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Filgotinib Tablets Tier 1, Tier 2, and Tier 3
4 Filgotinib Tablets Market by Type
  1. 4.1 Filgotinib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 200mg per Tablet
  4. 4.2 Global Filgotinib Tablets Sales by Type
  5. 4.2.1 Global Filgotinib Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Filgotinib Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Filgotinib Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Filgotinib Tablets Revenue by Type
  9. 4.3.1 Global Filgotinib Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Filgotinib Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Filgotinib Tablets Revenue Market Share by Type (2021-2032)
5 Filgotinib Tablets Market by Application
  1. 5.1 Filgotinib Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Filgotinib Tablets Sales by Application
  6. 5.2.1 Global Filgotinib Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Filgotinib Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Filgotinib Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Filgotinib Tablets Revenue by Application
  10. 5.3.1 Global Filgotinib Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Filgotinib Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Filgotinib Tablets Revenue Market Share by Application (2021-2032)
6 Global Filgotinib Tablets Sales by Region
  1. 6.1 Global Filgotinib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgotinib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Filgotinib Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Filgotinib Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Filgotinib Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Filgotinib Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Filgotinib Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Filgotinib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Filgotinib Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Filgotinib Tablets Revenue by Region
  1. 7.1 Global Filgotinib Tablets Revenue by Region
  2. 7.1.1 Global Filgotinib Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Filgotinib Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Filgotinib Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Filgotinib Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Filgotinib Tablets Revenue (2021-2032)
  8. 7.2.2 North America Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Filgotinib Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Filgotinib Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Filgotinib Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Filgotinib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alfasigma
  2. 8.1.1 Alfasigma Company Information
  3. 8.1.2 Alfasigma Business Overview
  4. 8.1.3 Alfasigma Filgotinib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alfasigma Filgotinib Tablets Product Portfolio
  6. 8.1.5 Alfasigma Recent Developments
  7. 8.2 Gilead Sciences
  8. 8.2.1 Gilead Sciences Company Information
  9. 8.2.2 Gilead Sciences Business Overview
  10. 8.2.3 Gilead Sciences Filgotinib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Gilead Sciences Filgotinib Tablets Product Portfolio
  12. 8.2.5 Gilead Sciences Recent Developments
  13. 8.3 Eisai
  14. 8.3.1 Eisai Company Information
  15. 8.3.2 Eisai Business Overview
  16. 8.3.3 Eisai Filgotinib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eisai Filgotinib Tablets Product Portfolio
  18. 8.3.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgotinib Tablets Value Chain Analysis
  2. 9.1.1 Filgotinib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgotinib Tablets Production Mode & Process
  6. 9.2 Filgotinib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgotinib Tablets Distributors
  9. 9.2.3 Filgotinib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst